Demetrios Braddock

This inventor holds 26 USPTO granted patents and 20 published patent applications and 3 EPO patents, primarily in Pathological Calcification. Top assignees: Yale University, Inozyme Pharma, Inc., The Ohio State University. Active years: 2017-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Demetrios Braddock. Retrieved from https://idiyas.com/inventor/demetrios-braddock

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 26 (Patent Applications = 20)

% Patents Active = 100.0

EPO Patents = 3 (Patent Applications = 19)

Average Co-Inventor Count = 2.1

ph-index = 7

Forward Citations = 100(Granted Patents)

Company Filing History:

The Ohio State University

patents

4. 1 out of 3,696

The United States of America, as Represented by the Secretary, Department of Health and Human Services

patents

where one patent can have more than one assignee

Years Active: 2017-2026

Loading Chart...

Areas of Expertise:

Soluble ENPP1 Proteins

Pathological Calcification

Periodontal Health

CXCR5 Antagonists

Nephrolithiasis

Stroke Prevention

NSAID Associated Coagulopathy

Pseudoxanthoma Elasticum

Hemophilia

Thrombocytopenia

Ossification

Coagulation Modulation

26 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12698487 - SOLUBLE ENPP1 PROTEINS AND USES THEREOF (2026-08-04),

2. 12589137 - Compositions and Methods for Treating Pathological Calcification and Ossification (2026-03-31),

3. 12478662 - TNAP LOCALLY ADMINISTERED FOR PROMOTING PERIODONTAL HEALTH (2025-11-25),

4. 12414927 - CXCR5 antagonists and methods of treating diseases or disorders using same (2025-09-16),

5. 12344868 - ENPP1 polypeptides and methods of using same (2025-07-01),

6. 12234489 - Compositions for treating ectopic calcification disorders, and methods using same (2025-02-25),

7. 12157903 - Compositions and methods for reducing progression of nephrolithiasis (2024-12-03),

8. 12128087 - Compositions for treating pathological calcification conditions, and methods using same (2024-10-29),

9. 11390859 - Compositions and methods for stroke prevention in pediatric sickle cell anemia patients (2022-07-19),

10. 11266722 - Compositions and methods for treating pathological calcification and ossification (2022-03-08),

11. 11123408 - Compositions and methods for treating nonsteroidal anti-inflammatory drug (NSAID) associated coagulopathy, thrombocytopenia, glanzmann's thrombasthenia, and/or thrombosis (2021-09-21),

12. 11090359 - Compositions for treating pathological calcification conditions, and methods using same (2021-08-17),

13. 10960050 - Methods for treating pseudoxanthoma elasticum (PXE) (2021-03-30),

14. 10960049 - Compositions for treating pathological calcification conditions, methods, and host cells using the same (2021-03-30),

15. 10624958 - Compositions and methods for treating pathological calcification and ossification (2020-04-21),

Title: **Demetrios Braddock: Innovator in Medical Treatments and Pathological Disorders**

Introduction

Demetrios Braddock is a distinguished inventor based in Guilford, CT, who holds an impressive portfolio of 21 patents. His work primarily focuses on compositions and methods aimed at treating various medical disorders, particularly those associated with calcification and nephrolithiasis.

Latest Patents

Among his latest innovations are groundbreaking patents that include "Compositions for treating ectopic calcification disorders, and methods using same," which presents compositions and methods for addressing diseases linked to pathological calcification or ossification. Another notable patent is titled "Compositions and methods for reducing progression of nephrolithiasis," which details methods for treating and preventing kidney stones using specific ENPP1 and ENPP3 polypeptides, or their mutant variants.

Career Highlights

Demetrios Braddock has built a career rich in impactful contributions, with notable positions at Yale University. His expertise and innovative mindset have led to significant advancements in medical treatments, paving the way for improved patient outcomes.

Collaborations

Demetrios has partnered with fellow professionals, including Ronald Albright and Clemens Bergwitz. These collaborations enhance the breadth of knowledge and innovation within his field of expertise.

Conclusion

Through his inventive work and collaborations, Demetrios Braddock continues to make noteworthy contributions to medical science. His patents and ongoing research serve as a testament to his dedication and expertise, driving forward the frontier of treatments for complex medical conditions.

Profile summary based on public USPTO records.